United States: The More Things Change In Marijuana Investment Law, The More Things Stay The Same

Voters in eight states legalized marijuana on November 8: recreational marijuana in California, Maine, Massachusetts and Nevada and medical marijuana in Arkansas, Florida, Montana and North Dakota. More than one-fifth of all Americans now live in states with legal recreational marijuana markets, a number that nearly quadrupled in size overnight. Investors hoping to capitalize on new opportunities nonetheless face continued risks. This article summarizes the current state of the market and highlights certain of the ongoing obstacles to investing in marijuana companies.

Marijuana Investment Activity Update

The total marijuana market (recreational and medical) is on pace to reach $7 billion in sales this year, and some analysts predict it could exceed $20 billion by 2020. Revenues will of course depend on how quickly new licenses are issued. States with new regimes do not have to recreate the wheel, in terms of tax rates, licensing procedures, safety requirements, etc., as early-adopter states (Colorado, Washington) have created the road map, and the new state propositions included detailed provisions for the regulation of marijuana. These states can therefore jump out of the gate with a running start once licenses are issued in 2017 or early 2018. Meanwhile, attitudes toward marijuana will also affect sales, and recent polling by Gallup shows 60% of Americans support legalizing marijuana, historically high levels. Finally, competition from the underground market, mostly on price, continues to be an issue, but the price of legal marijuana is falling as the number of retail dispensaries rises and the cost of production falls.

Yet despite the momentum, marijuana companies still lack adequate access to capital and financial services. This is because marijuana's federal illegality creates money-laundering issues and poses reputational and other risks for many traditional institutional investors. Although the big banks have not ventured into the market, there has been restrained interest, particularly in the medical marijuana field, that may develop once federal obstacles are removed. In the meantime, to fill the void, several specialized funds have completed or are currently seeking, in the wake of the state election results, to complete financing rounds, including Tuatara Capital, which successfully closed a $93 million raise, and Privateer Holdings, which used proceeds from a March 2015 $75 million raise to invest in Leafly (a review aggregator for marijuana strains), Marley Natural (a brand licensed from Bob Marley's family) and Tilray (a Canadian medical marijuana company) and has recently raised another $40 million.

This activity is part of a larger landscape of investment that one company (Viridian Capital Advisors) estimated to total more than 250 capital raises worth over $800 million in 2016. Equity raises substantially outnumbered debt raises, perhaps in part because marijuana businesses are generally prohibited by Section 280E of the Internal Revenue Code from taking business tax deductions, so interest payments on debt do not offset income (see below discussion), and perhaps because investors want to be positioned to capitalize on their investment in marijuana.

Some investors are interested in the market but have focused on products and services ancillary to the marijuana industry because such investments have less regulatory uncertainty and business risk. Microsoft made headlines for announcing it was partnering with Kind Financial to provide software that will help marijuana-related businesses comply with "seed to sale" tracking laws and regulations. Marijuana agricultural equipment has seen much activity, headlined by Scotts Miracle-Gro's 2015 $135 million acquisition of two hydroponics equipment manufacturers. Although many pharmaceutical companies have opposed liberalization policies, others have invested millions researching drugs containing synthetic cannabinoids, such as GW Pharmaceuticals' Sativex. And in October, a marijuana-focused real estate investment trust filed disclosures with the Securities and Exchange Commission as part of a $175 million public offering, describing plans to acquire marijuana-growing facilities and engage in leaseback deals with marijuana companies, thereby freeing capital for marijuana companies to focus on growing and retail operations.

Investors are also watching Canadian and Mexican policies with interest because of the potential for sales and because prohibition policies will become increasingly difficult to enforce as American neighbors liberalize their policies. In Canada, medical marijuana has been legal since 2001 and recreational marijuana is expected to be legalized by the spring of 2017. In Mexico, the Supreme Court in 2015 found the world's first constitutional right for marijuana use, which, together with President Enrique Peña Nieto's proposal to legalize marijuana, has bolstered legalization momentum in the country.

Marijuana Regulatory Update

The marijuana industry's growth has been, and continues to be, held back by federal policy, including marijuana's classification as a Schedule 1 drug, which means marijuana businesses:

  • May generally not take business tax deductions because of Section 280E of the Internal Revenue Code (which prohibits deductions for businesses trafficking in controlled substances) – although Section 280E does not prohibit a deduction for cost of goods sold, it precludes all other traditional business expense deductions.
  • Struggle to access banking services; those who do often pay steep fees to offset banks' regulatory and compliance burdens.
  • Have little recourse if federal enforcement policy changes.

In response to a 2015 letter by eight U.S. senators calling for the DEA to review marijuana's classification, the DEA in the summer of 2016 ultimately declined to reclassify marijuana, relying on analysis by the Department of Health and Human Services that there is no currently accepted medical use of marijuana. Despite this decision, now that more than half the states have legalized medical marijuana and scientific research will be easier going forward (the University of Mississippi no longer has a monopoly on producing marijuana to be used for clinical trials seeking federal approvals), marijuana may yet be reclassified in the future. Reclassification will also depend on President-elect Trump's political appointments and policies – he has recently expressed support for states' rights on medical marijuana, but he has also referred to Colorado's regime as a "real problem" – so time will tell how the new government will enforce marijuana laws.

Looking Forward

We will continue to monitor this exciting and rapidly evolving market.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.